International Publisher of Science, Technology and Medicine

 

Jianxun Song

Jianxun Song

Jianxun Song, PhD

Department of Microbiology and Immunology

The Pennsylvania State University College of Medicine, USA

 

Biography

Dr. Jianxun (Jim) Song is a tenured associate professor in the Department of Microbiology and Immunology, the Pennsylvania State University College of Medicine, United States. The base of expertise on T cell biology needed to perform his research began to develop while he was a postdoctoral scholar and research scientist from the years 2001-2007 under the mentorship of Dr. Michael Croft at the La Jolla Institute for Allergy and Immunology. He became a junior faculty at The Pennsylvania State University College of Medicine in 2007, and extended his research on Developmental Immunology and Stem Cell Biology. As a PI on previous university-, foundation-, or NIH-funded grants, he laid the groundwork for the research by developing highly reactive T lymphocytes from pluripotent stem cells (PSC). His laboratory was the first to show that induced PSC differentiate into functional T cells for cell-based therapies. In addition to having the expertise to be successful with the research, he offers leadership and administrative skills that were developed during his independence as a mentor of graduate students and postdoctoral scholars. In summary, he has a demonstrated record of successful and productive research projects in the area.

Research Interest

Dr. Jianxun (Jim) Song research interests include: T cell biology, Immunotherapy, Stem cells, Autoimmunity, Signal transduction.

Publications

About Drunkard and the Keys which were Not Found
Editorial:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000e101
Alexander B Poletaev and Majia H Nadesan
Abstract  |   Full-text  |   PDF  |  
New Ways to Design Vaccines: Nanodelivery, Cancer Vaccines and Systems Biology
Editorial:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000e102

Ales Prokop

Abstract  |   Full-text  |   PDF  |  
Current Challenges for the Anti-Devil Facial Tumor Disease (DFTD) Vaccine Development
Editorial:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000e103
Noah Isakov
Abstract  |   Full-text  |   PDF  |  
Enhancement of Infection by Pre-Existing Non-Neutralizing Antibodies to Cross-Reactive Flaviviruses: Ramifications for Vaccination against Dengue and Zika
Commentary:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000101
Andrew W Taylor-Robinson
Abstract  |   Full-text  |   PDF  |  
Vaccine Related Myocarditis
Review Article:  J Vacc Clin Trials 2017, 1:1
doi: 10.4172/jvct.1000102
Manasa B, Harshita T and Mounika Y
Abstract  |   Full-text  |   PDF  |  
 
izmit escort sex geschichten escort bayan porno sikis adult porno pornolar
anakara escort
test